Olanzapine-induced Neuroleptic Malignant Syndrome

Neuroleptic malignant syndrome (NMS) is a life-threatening adverse effect usually seen with typical antipsychotic drugs. Rarely, NMS can occur with atypical antipsychotics also. A 19-year-old male diagnosed as a case of acute and transient psychotic disorder developed NMS, following the treatment wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Pradeep Kumar, Chakraborty, Abhijit, Layek, Avik Kumar, Chakraborty, Aritra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461854/
https://www.ncbi.nlm.nih.gov/pubmed/28615778
http://dx.doi.org/10.4103/0253-7176.207320
_version_ 1783242415980675072
author Saha, Pradeep Kumar
Chakraborty, Abhijit
Layek, Avik Kumar
Chakraborty, Aritra
author_facet Saha, Pradeep Kumar
Chakraborty, Abhijit
Layek, Avik Kumar
Chakraborty, Aritra
author_sort Saha, Pradeep Kumar
collection PubMed
description Neuroleptic malignant syndrome (NMS) is a life-threatening adverse effect usually seen with typical antipsychotic drugs. Rarely, NMS can occur with atypical antipsychotics also. A 19-year-old male diagnosed as a case of acute and transient psychotic disorder developed NMS, following the treatment with an atypical antipsychotic, olanzapine 20 mg/day. The patient was diagnosed NMS, an offending agent olanzapine was immediately withdrawn, and prompt treatment by maintaining hydration and giving bromocriptine produced recovery.
format Online
Article
Text
id pubmed-5461854
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-54618542017-06-14 Olanzapine-induced Neuroleptic Malignant Syndrome Saha, Pradeep Kumar Chakraborty, Abhijit Layek, Avik Kumar Chakraborty, Aritra Indian J Psychol Med Case Report Neuroleptic malignant syndrome (NMS) is a life-threatening adverse effect usually seen with typical antipsychotic drugs. Rarely, NMS can occur with atypical antipsychotics also. A 19-year-old male diagnosed as a case of acute and transient psychotic disorder developed NMS, following the treatment with an atypical antipsychotic, olanzapine 20 mg/day. The patient was diagnosed NMS, an offending agent olanzapine was immediately withdrawn, and prompt treatment by maintaining hydration and giving bromocriptine produced recovery. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5461854/ /pubmed/28615778 http://dx.doi.org/10.4103/0253-7176.207320 Text en Copyright: © 2017 Indian Psychiatric Society http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Saha, Pradeep Kumar
Chakraborty, Abhijit
Layek, Avik Kumar
Chakraborty, Aritra
Olanzapine-induced Neuroleptic Malignant Syndrome
title Olanzapine-induced Neuroleptic Malignant Syndrome
title_full Olanzapine-induced Neuroleptic Malignant Syndrome
title_fullStr Olanzapine-induced Neuroleptic Malignant Syndrome
title_full_unstemmed Olanzapine-induced Neuroleptic Malignant Syndrome
title_short Olanzapine-induced Neuroleptic Malignant Syndrome
title_sort olanzapine-induced neuroleptic malignant syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461854/
https://www.ncbi.nlm.nih.gov/pubmed/28615778
http://dx.doi.org/10.4103/0253-7176.207320
work_keys_str_mv AT sahapradeepkumar olanzapineinducedneurolepticmalignantsyndrome
AT chakrabortyabhijit olanzapineinducedneurolepticmalignantsyndrome
AT layekavikkumar olanzapineinducedneurolepticmalignantsyndrome
AT chakrabortyaritra olanzapineinducedneurolepticmalignantsyndrome

Ejemplares similares